664 Initial Findings of Safety and Efficacy from the Multicenter, Open-Label, Phase I Study of Titaprutug (TWP-102), an Anti-Ctla-4 Antibody, in the Patients(pts) with Advanced Malignant Tumors

Qingyuan Zhang, Jingxuan Wang, Liru Li, Ying Song, Wenhui Zhao,Han Zhang,Xingjian Niu,Yue Zhang, Xin Gao, DongXiao Feng, Shengbin Ren, Zhongyi Shen, Gaijin Xue, Miao He, Meinan Zheng, Haiou Guo, Yujie Liu, Xiujie Pan, Guili Xu, Jianqing Zhang

Regular and Young Investigator Award Abstracts（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined